Women of Sweden Cohort
Citation and access
Citation and access
Data access level:
Creator/Principal investigator(s):
Research principal:
Citation:
Method and outcome
Method and outcome
Unit of analysis:
Population:
Swedish women aged 23-60 years.
Time method:
Sampling procedure:
Time period(s) investigated:
Data format/data structure:
Data collection - Physical measurements and tests
Data collection - Physical measurements and tests
Mode of collection:
Physical measurements and tests
Time period(s) for data collection:
1970 - Ongoing
Source of the data:
- Population group
Geographic coverage
Geographic coverage
Geographic description:
Sweden
Administrative information
Administrative information
Responsible department/unit:
Department of Clinical Science, Intervention and Technology [H9]
Funding
Funding
Funding agency:
- Swedish Research Council
Opens a new window at ror.org.
ROR
Award number:
2014-03732_VR
Award title:
Nationwide audit of cervical screening in Sweden
Funding information:
The main purpose of this proposed study is to perform a comprehensive population-based evaluation of strengths and weaknesses of the currently used preventive strategies for cervical cancer (so-called Audit). Cervical cancer morbidity and mortality will be evaluated in relation to the performance of the current Swedish cervical screening program, and we will set a benchmark for the evaluation of new screening methods with HPV based screening and for HPV vaccination. With large-scale HPV-typing of all cervical cancer tumors in Sweden during the years 2002-2011 we will create a nation-wide baseline of type-specific HPV prevalence, by age and histo-pathological type, as well as detailed screening history that will be gathered from the National Quality Register for Cervical Cancer Prevention, encompassing up to 40 years of screening experience in Sweden. Ten controls acquired from the Total Population Register will be assigned to each case, and data from the Quality Register will be linked to controls as well. The results gained from this study will be obtained from a real-life, nation-wide, clinical cancer population, and will therefore be of considerably high validity that is rarely available from scientific studies. A complete set of all cervical cancers diagnosed during a decade in Sweden lacks comparison internationally and would indeed serve as a rarely-seen initiative. The results will be applicable to real-life screening practices within the near future.
